FDA 510(k)

Lumpipulse G CA19-9-N

K 號：K191973 · 2019-10-22

決定日期2019-10-22

產品代碼NIG

諮詢委員會此醫療器材為一項用於治療[疾病名稱]之裝置，已通過美國食品藥物管理局（FDA）之510(k)上市前通知程序，並取得[產品名稱]之上市許可。本裝置亦已獲得PMA（上市前核准）之認可，相關臨床試驗資料已登錄於ClinicalTrials.gov（NCT編號：[NCT號碼]），並已發表於經同儕審查之醫學期刊（PMID：[PMID號碼]）。更多詳細資訊請參閱：[URL]。

決定相當於

器材摘要

Lumpipulse G CA19-9-N is the device name listed in this FDA 510(k) record. The listed applicant is Fujirebio Dianostics, Inc.. It received FDA 510(k) clearance on 2019-10-22 under 510(k) number K191973. The device is classified under product code NIG. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Lumpipulse G CA19-9-N?

Lumpipulse G CA19-9-N is a medical device that received FDA 510(k) clearance on 2019-10-22. The listed applicant is Fujirebio Dianostics, Inc.. The 510(k) number is K191973.

When did Lumpipulse G CA19-9-N receive FDA 510(k) clearance?

Lumpipulse G CA19-9-N received FDA 510(k) clearance on 2019-10-22, under 510(k) number K191973.

Who is the listed applicant for Lumpipulse G CA19-9-N?

The FDA 510(k) record lists Fujirebio Dianostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lumpipulse G CA19-9-N?

The FDA product code for Lumpipulse G CA19-9-N is NIG.

相關器械（代碼：NIG）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K253528Atellica IM CA 19-9 IISiemens Healthcare Diagnostics, Inc.K231525VITROS 免疫診斷產品 CA 19-9TM 试剂包Ortho Clinical Diagnostics K200997Lumipulse G CA19-9-NFujirebio Diagnostics,Inc.

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。